The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Recent identification in bone of transporters, receptors, and components of synaptic signaling suggests a role for glutamate in the skeleton. We investigated effects of glutamate and its antagonist MK801 on osteoclasts in vitro. Glutamate applied to patch clamped osteoclasts induced significant increases in whole‐cell membrane currents ( P <0.01) in the presence of the coagonist glycine. Agonist‐elicited currents were significantly decreased after application of MK801 (100 µM, P <0.01), butMK801 had no effect on actin ring formation necessary for osteoclast polarization, attachment, and resorption. In cocultures of bone marrow cells and osteoblasts in which osteoclasts develop, MK801 inhibited osteoclast differentiation and reduced resorption of pits in dentine (3 to 100 µM; P <0.001). MK801 added early in the culture (for as little as 2–4 days) was as effective as addition for the entire culture period. Addition of MK801 for any time after day 7 of culture was ineffective in reducing osteoclast activity. Using rat and rabbit mature osteoclasts cultured on dentine or explants of mouse calvariae prelabeled with 45 Ca, we could not detect significant effects of MK801 on osteoclastic resorption. These data show clearly that glutamate receptor function is critical during osteoclastogenesis and suggest that glutamate is less important in regulating mature osteoclast activity.—Peet, N. M., Grabowski, P. S., Laketić‐Ljubojević, I., Skerry, T. M. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J. 13, 2179–2185 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Tetrameric Structure of a Glutamate Receptor Channel
Rosenmund, C., Stern-Bach, Y., & Stevens, C. F. (1998) · Science · doi:10.1126/science.280.5369.1596 · Cited by 794
Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death
Forrest, D., Yuzaki, M., Soares, H. D., Ng, L., Luk, D. C., Sheng, M., Stewart, C. L., Morgan, J. I., Connor, J. A., & Curran, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90350-6 · Cited by 491
Cited by
Spencer, G. J., Utting, J. C., Etheridge, S. L., Arnett, T. R., & Genever, P. G. (2006) · Journal of Cell Science · doi:10.1242/jcs.02883 · Cited by 334
Glutamate signalling in non-neuronal tissues
Skerry, T. M., & Genever, P. G. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01642-4 · Cited by 307
Self-citationGlutamate antagonists limit tumor growth
Rzeski, W., Turski, L., & Ikonomidou, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091113598 · Cited by 287
Nuttall, M. E., & Gimble, J. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00317-3 · Cited by 286
Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts
Hinoi, E., Fujimori, S., Nakamura, Y., & Yoneda, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4355 · Cited by 80
Metadata
- Authors
- PEET, N. M., GRABOWSKI, P. S., LAKETIć‐LJUBOJEVIć, I., & SKERRY, T. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-12
- Volume
- 13
- Issue
- 15
- Pages
- 2179-2185
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1868834139
- Cited by
- 108
- References
- 2
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. https://app.cochat.ai/papers/10.1096/fasebj.13.15.2179
- The paper
- PEET, N. M., GRABOWSKI, P. S., LAKETIć‐LJUBOJEVIć, I., & SKERRY, T. M. (1999). The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. The FASEB Journal. https://doi.org/10.1096/fasebj.13.15.2179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.